30 Aug 2017
Spontaneous haematoma, dissection: a broken heart bleeds tears
2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT)
04 Sep 2017
As dual antiplatelet therapy (DAPT) seems to have been interventionalists’ close companion since the pioneering studies showing its benefits over oral anticoagulants (OAC) some 20 years ago, the myriad of ensuing studies has led to expanding indications, but has also uncovered the inherent risks of DAPT. In the 2017 Focused Update, the hitherto accumulated evidence is eloquently summarized into a set of recommendations that provide guidance on some of the important questions of an interventional cardiologist's everyday practice: which of the currently available P2Y12 inhibitors should be selected, what is the optimal duration of DAPT and how to manage bleeding complications.
Oxygen Therapy in Suspected Acute Myocardial Infarction
30 Aug 2017
New ESC Guidelines on Acute Myocardial Infarction in patients presenting with ST-segment elevation (STEMI)
30 Aug 2017
Within the four guidelines released at the ESC Congress 2017, the STEMI guidelines may probably represent one of the most interesting for our community. Many of the changes in recommendations were already expected by many of us, whereas others are important to see and to digest.
VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI: Antithrombotic Therapy takes the stage
In the accompanying editorial of COMPASS, presented at the ESC Congress 2017 in Barcelona, Eugene Braunwald vividly referred to the field of “Thrombocardiology”. Indeed, the topic of antithrombotic pharmacotherapy is now broader than ever, with plenty of drugs, indications, strategies and clinical data. Three new trials (with simultaneous publications in the New England Journal of Medicine and in The Lancet) clarify doubts, inform clinical practice and open new questions.
Ticagrelor or clopidogrel in DAPT for acute coronary syndromes: A call for a stepwise approach?
COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction
10 Aug 2017
At least seven days delayed stenting using minimalist immediate mechanical intervention (MIMI) in ST-segment elevation myocardial infarction: the SUPER-MIMI study
02 Aug 2017
EuroPCR 2017 Highlights: Coronary Interventions
20 May 2017 - From EUROPCR 2017
From the standpoint of 40 years of angioplasty, 20 years of physiological assessment and emerging data on a variety of topics, J. Byrne and T. Johnson review data published at EuroPCR 2017. Interest remains intense concerning bioresorbable stents (BRS) with ongoing international trials and whether evolving new devices and techniques will answer the problem of thrombosis. Complex interventions such as CTO showed interesting data and the evolution in our use of iFR or FFR continues to demonstrate the role innovation plays in our specialty, hereby better understanding physiology to improve treatment strategies and positively impacting outcome.
Will COMPARE-ACUTE change my practice?
19 May 2017 – From EuroPCR 2017